| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 800.0K | $1.06M | - | |
| Other | 400.0K | $528.0K | - | |
| Other | 30.0K | $39.6K | - | |
| Dir | 29.8K | $39.3K | - | |
| Dir | 29.2K | $38.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Vitoc Vlad | Chief Executive Officer | Buy | 11,800 | $0.98 | $11,547.00 | +0.7% | +118.4% | - | |
| Oct 1, 2025 | Smith Stan | Director | Buy | 19,230 | $1.30 | $24,999.00 | +1.5% | -19.9% | - | |
| Jun 3, 2025 | Smith Stan | Director | Buy | 33,333 | $1.50 | $49,999.50 | +2.6% | -14.3% | - | |
| May 8, 2025 | Smith Stan | Director | Buy | 66,666 | $1.50 | $99,999.00 | +5.5% | -22.4% | - | |
| May 8, 2025 | Guerrero Ramiro | Director | Buy | 20,000 | $1.50 | $30,000.00 | +3.5% | -22.4% | - | |
| Mar 3, 2025 | Smith Stan | Director | Buy | 25,000 | $1.50 | $37,500.00 | +2.1% | +2.9% | -11.2% | |
| Mar 3, 2025 | Guerrero Ramiro | Director | Buy | 33,333 | $1.50 | $49,999.50 | +6.2% | +2.9% | -11.2% | |
| Feb 24, 2025 | Guerrero Ramiro | Director | Buy | 73,333 | $1.50 | $109,999.50 | +15.9% | -1.7% | +33.7% | |
| Feb 24, 2025 | Smith Stan | Director | Buy | 50,000 | $1.50 | $75,000.00 | +4.4% | -1.7% | +33.7% | |
| Dec 13, 2024 | Guerrero Ramiro | Director | Buy | 53,418 | $1.87 | $99,998.50 | +11.6% | -21.0% | -32.0% |